Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-12 · accession 0000899243-22-014804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-14 | 2022-04-12+ | VRTX | Lee Yuchun | Dir | S - Sale+OE | $284.27 | -4,000 | 3,029 | -57% | -$1.14M |
| DM | 2022-04-14 | 2022-04-12+ | VRTX | Lee Yuchun | Dir | M - OptEx | $81.54 | +4,000 | 3,875 | New | +$326.2K |
| DM | 2022-04-14 | 2022-04-12+ | VRTX | Lee Yuchun | Dir | M - OptEx | $0.00 | -4,000 | 4,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-13 | S | D | 18 | $281.49 | 3,857 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-13 | S | D | 354 | $291.12 | 1,875 | D | — | — | (F13) Open market sales reported on this line occurred at a weighted average price of $291.12 (range $290.80 to $291.42). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-04-13 | S | D | 200 | $290.17 | 2,229 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F12) Open market sales reported on this line occurred at a weighted average price of $290.17 (range $289.72 to $290.62). |
| 4 | Common | Common Stock | 2022-04-13 | S | D | 400 | $288.55 | 2,429 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F11) Open market sales reported on this line occurred at a weighted average price of $288.55 (range $288.23 to $289.11). |
| 5 | Common | Common Stock | 2022-04-13 | S | D | 200 | $287.42 | 2,829 | D | — | — | (F10) Open market sales reported on this line occurred at a weighted average price of $287.42 (range $287.02 to $287.83). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2022-04-12 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 7 | Common | Common Stock | 2022-04-12 | S | D | 200 | $279.22 | 3,675 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $279.22 (range $279.14 to $279.30). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2022-04-12 | S | D | 1,182 | $280.61 | 2,493 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $280.61 (range $280.24 to $281.19). |
| 9 | Common | Common Stock | 2022-04-12 | S | D | 318 | $281.70 | 2,175 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $281.70 (range $281.45 to $281.98). |
| 10 | Common | Common Stock | 2022-04-12 | S | D | 300 | $283.15 | 1,875 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $283.15 (range $282.73 to $283.57). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2022-04-13 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 12 | Common | Common Stock | 2022-04-13 | S | D | 300 | $283.73 | 3,557 | D | — | — | (F7) Open market sales reported on this line occurred at a weighted average price of $283.73 (range $283.30 to $284.10). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 13 | Common | Common Stock | 2022-04-13 | S | D | 228 | $284.90 | 3,329 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $284.90 (range $284.66 to $284.95). |
| 14 | Common | Common Stock | 2022-04-13 | S | D | 300 | $286.24 | 3,029 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F9) Open market sales reported on this line occurred at a weighted average price of $286.24 (range $285.99 to $286.60). |
| 15 | Derivative | Stock Option (Right to Buy) | 2022-04-12 | M | D | 2,000 | $0.00 | 6,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F14) Fully vested. |
| 16 | Derivative | Stock Option (Right to Buy) | 2022-04-13 | M | D | 2,000 | $0.00 | 4,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F14) Fully vested. |